Details for New Drug Application (NDA): 215138
✉ Email this page to a colleague
The generic ingredient in BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE is acetaminophen; butalbital; caffeine; codeine phosphate. There are sixty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine; codeine phosphate profile page.
Summary for 215138
Tradename: | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE |
Applicant: | Hikma |
Ingredient: | acetaminophen; butalbital; caffeine; codeine phosphate |
Patents: | 0 |
Pharmacology for NDA: 215138
Mechanism of Action | Full Opioid Agonists |
Physiological Effect | Central Nervous System Stimulation |
Suppliers and Packaging for NDA: 215138
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | acetaminophen; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 215138 | ANDA | Hikma Pharmaceuticals USA Inc. | 0054-0650 | 0054-0650-25 | 100 CAPSULE in 1 BOTTLE (0054-0650-25) |
BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | acetaminophen; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 215138 | ANDA | Hikma Pharmaceuticals USA Inc. | 0054-3000 | 0054-3000-01 | 100 CAPSULE in 1 BOTTLE (0054-3000-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 325MG;50MG;40MG;30MG | ||||
Approval Date: | Jan 26, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 300MG;50MG;40MG;30MG | ||||
Approval Date: | Jan 26, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription